UID:
almahu_9948026588602882
Umfang:
1 online resource (413 pages) :
,
illustrations
ISBN:
0-08-102249-2
,
0-08-102237-9
Anmerkung:
Front Cover -- Vicinal Diaryl Substituted Heterocycles: A Gold Mine for the Discovery of Novel Therapeutic Agents -- Copyright -- Contents -- Contributors -- Foreword -- Preface -- List of Abbreviations -- Chapter 1: Vicinal Diaryl Heterocyclic System: A Privileged Scaffold in the Discovery of Potential Therapeutic Agents -- 1.1 Brief Perspective of Heterocyclic Compounds -- 1.2 Vicinal Diaryl-Substituted Heterocyclic Systems -- 1.3 Importance of VDHS in the Discovery of Therapeutic Agents -- 1.3.1 Clinically Used Drugs -- 1.3.2 Therapeutically Potential Compounds -- 1.3.2.1 Anticancer Agents -- 1.3.2.2 COX-2 Inhibitors -- 1.3.2.3 Antihypercholesterolemic Agents -- 1.3.2.4 Antiviral Agents -- 1.3.2.5 CB1 Receptor Antagonists -- 1.3.2.6 Antimicrobial Agents -- 1.3.2.7 Miscellaneous Agents -- 1.4 Concluding Remarks -- References -- Chapter 2: Therapeutic Potential of Vicinal Diaryl Azetidin-2-ones -- 2.1 Synthesis of Vicinal Diaryl Azetidin-2-Ones -- 2.1.1 The Staudinger Reaction (Ketene-Imine Reaction) -- 2.1.2 Enolate-Imine Condensation Reaction -- 2.1.3 The Mitsunobu Reaction -- 2.2 Biological Spectrum of Vicinal Diaryl Azetidin-2-Ones -- 2.2.1 Cholesterol Absorption Inhibitors -- 2.2.2 Antiproliferative Agents -- 2.2.3 Antimicrobial and Antitubercular Agents -- 2.2.4 Anti-inflammatory and Analgesic Agents -- 2.3 Conclusion -- References -- Chapter 3: Vicinal Diaryl Pyrroles: Synthesis and Biological Aspects -- 3.1 Introduction -- 3.2 Synthesis of Different Vicinal Diaryl Pyrroles -- 3.3 Biological Spectrum of Vicinal Diaryl Pyrroles -- 3.3.1 Antiproliferative Agents -- 3.3.1.1 1,2-Diarylpyrroles -- 3.3.1.2 2,3-Diarylpyrroles -- 2,3-Diarylpyrroles as ER Binding Agents -- 3.3.1.3 3,4-Diarylpyrroles -- 3,4-Diarylpyrroles as VEGF-R Inhibitors -- 3.3.1.4 4,5-Diarylpyrroles -- 3.3.1.5 1,5-Diarylpyrroles.
,
3.3.2 Anti-inflammatory Agents/COX-2 Inhibitors -- 3.3.2.1 1,5-Diarylpyrroles -- 1,5-Diarylpyrroles as EP1 Receptor Antagonists -- 3.3.3 Antitubercular Agents -- 3.3.3.1 3,4-Diarylpyrroles -- 3.3.3.2 1,5-Diarylpyrroles -- 3.3.4 Anticoccidial Agents -- 3.3.4.1 2,3-Diarylpyrroles -- 3.3.5 1,5-Diarylpyrroles as Carbonic Anhydrase IX (hCA IX) Inhibitors -- 3.4 Conclusion -- References -- Chapter 4: Synthesis and Biological Profiles of 4,5-, 1,5-, and 1,2-Diaryl-1H-imidazoles -- 4.1 Introduction -- 4.2 4,5-Diaryl-1H-Imidazoles -- 4.2.1 Synthetic Methods -- 4.2.2 Biological and Pharmacological Properties of 4,5-Diaryl-1H-imidazoles -- 4.2.2.1 Anticancer Agents -- Cytotoxic Compounds -- Cytotoxic Compounds with Antivascular Effects -- Cytotoxic Compounds with Tubulin Inhibitory Activity -- Indoleamine 2,3-Dioxygenase Inhibitors -- 4.2.2.2 Inhibitors of Transforming Growth Factor-β Type 1 Receptor (ALK5) Kinase -- 4.2.2.3 Anti-inflammatory Agents -- Selective Cyclooxygenase-2 (COX-2) Inhibitors -- p38 MAP Kinase Inhibitors -- 4.2.2.4 Inhibitors of Casein Kinase 1δ (CK1δ) and Dual Inhibitors of CK1δ and p38 MAPK -- 4.2.2.5 Acyl-Coenzyme A: Cholesterol O-Acyltransferase (ACAT) Inhibitors -- 4.2.2.6 Cannabinoid CB1 Receptor Inverse Agonists -- 4.2.2.7 15-Lipoxygenase Inhibitors -- 4.2.2.8 Aspartyl Protease Inhibitors -- 4.2.2.9 Antimicrobial Agents -- 4.2.2.10 Glutamine Synthetase Inhibitors -- 4.2.2.11 α-Glucosidase Inhibitors -- 4.2.2.12 B-Raf Kinase Inhibitors -- 4.3 1,5-Diaryl-1H-Imidazoles -- 4.3.1 Synthetic Methods -- 4.3.2 Biological and Pharmacological Properties of 1,5-Diaryl-1H-imidazoles -- 4.3.2.1 Cyclooxygenase-2 (COX-2) Inhibitors -- 4.3.2.2 Cytotoxic Compounds Including Vascular Disrupting Agents -- 4.3.2.3 Antinociceptive Agents -- 4.4 1,2-Diaryl-1H-Imidazoles -- 4.4.1 Synthetic Methods.
,
4.4.2 Biological and Pharmacological Properties of 1,2-Diaryl-1H-imidazoles -- 4.4.2.1 Cytotoxic Compounds -- 4.4.2.2 Selective Cyclooxygenase-2 (COX-2) Inhibitors -- 4.4.2.3 Inhibitors of Transforming Growth Factor-β Type 1 Receptor (ALK5) -- 4.4.2.4 Serotonin Reuptake Inhibitors -- 4.4.2.5 Cannabinoid CB1 Receptor Antagonists -- 4.5 Conclusions and Perspectives -- References -- Further Reading -- Chapter 5: Vicinal Diaryl Pyrazole: A Therapeutically Potential Molecular Scaffold -- 5.1 Introduction -- 5.2 Synthesis of Vicinal Diaryl Substituted Pyrazoles -- 5.2.1 Knorr Pyrazole Synthesis -- 5.2.2 1,3-Dipolar Cyclocondensation -- 5.3 Biological Activities of Vicinal Diaryl-Substituted Pyrazoles -- 5.3.1 Clinically Used Drugs -- 5.3.1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) -- 5.3.1.2 CB1 Antagonists (Anti-Obesity and Smoking Cessation Drugs) -- 5.3.1.3 Antidepressants -- 5.3.2 Molecules with Promising Bioactivities -- 5.3.2.1 Anti-Inflammatory Activity -- 5.3.2.2 Anticancer Activity -- 3,4-Diaryl Pyrazoles -- 4,5-Diaryl Pyrazoles -- 1,5-Diaryl Pyrazoles -- 5.3.2.3 Antibacterial Activity -- 5.3.2.4 Antimycobacterial Activity -- 3,4-Diaryl Pyrazoles -- 1,5-Diaryl Pyrazoles -- 5.3.2.5 CB1R Antagonists -- 5.3.2.6 Hypoglycemic Activity -- 5.3.2.7 Antioxidant Activity -- 5.3.2.8 Antiviral Activity -- 5.4 Conclusion -- References -- Chapter 6: Vicinal Diaryl Triazoles and Tetrazoles -- 6.1 Introduction -- 6.2 Vicinal Diaryl Triazoles and Tetrazoles -- 6.2.1 Synthesis of 1,5- and 4,5-Diaryl-1,2,3-Triazoles -- 6.2.2 Synthesis of 1,5-, 3,4-, and 4,5-Diaryl-1,2,4-Triazoles -- 6.2.3 Synthesis of 1,5-Diaryl Tetrazoles -- 6.3 Biological Spectrum of Vicinal Diaryl Triazoles and Tetrazoles -- 6.3.1 Anticancer Potential of Vicinal Diaryl Triazoles and Tetrazoles -- 6.3.2 Cyclooxygenase Inhibitory Potential of Vicinal Diaryl Triazoles and Tetrazoles.
,
6.3.3 Cannabinoid (CB1) Receptors Inhibitory Potential of Vicinal Diaryl Triazoles -- 6.3.4 Vicinal Diaryl Triazole-Containing Compounds having Miscellaneous Activities -- 6.4 Conclusion -- References -- Chapter 7: Synthesis and Biological Activities of Vicinal Diaryl Furans -- 7.1 Synthesis of Vicinal Diaryl Furans -- 7.1.1 Synthesis of Diaryl Furans by Dehydration of 1,4-Diketones -- 7.1.2 Synthesis of Diaryl Furans by Intramolecular Aldol Condensation -- 7.1.3 Synthesis of Diaryl Furanones by Condensation Reaction -- 7.1.4 Synthesis of Diaryl Furan-2,5-Diones From Benzoylformic Acid -- 7.1.5 Synthesis of Diaryl Hydroxyfuranones From Aryl Pyruvates -- 7.2 Vicinal Diaryl Furans as COX-2 Inhibitors -- 7.3 Vicinal Diaryl Furans as Anticancer Agents -- 7.4 Vicinal Diaryl Furans as Antioxidants and Anti-Inflammatory Agents -- 7.5 Vicinal Diaryl Furans as Dual COX-2 and LOX Inhibitors -- 7.6 Vicinal Diaryl Furans as Antifungal Agents -- 7.7 Vicinal Diaryl Furans as NO Donors -- 7.8 Conclusion -- References -- Chapter 8: Vicinal Diaryl Thiazoles and Thiadiazoles -- 8.1 Thiazoles -- 8.1.1 Synthesis of Vicinal Diaryl Thiazoles -- 8.1.1.1 Hantzsch Synthesis -- 8.1.2 Biological Properties of Vicinal Diaryl Thiazoles and Isothiazoles -- 8.1.2.1 Anti-Inflammatory Activity -- 8.1.2.2 Anticancer Activity -- 8.1.2.3 Anti-Alzheimer Activity -- 8.1.2.4 Cholesterol Lowering Agents -- 8.2 Thiazolines -- 8.2.1 Synthesis of Vicinal Diaryl Thiazolines -- 8.2.2 Biological Activities of Vicinal Diaryl Thiazolines -- 8.2.2.1 Anticancer, Analgesic, and Anti-Inflammatory Activities -- 8.3 Thiazolidinones -- 8.3.1 Synthesis of Vicinal Diaryl Thiazolidinones -- 8.3.2 Biological Activity of 1,3-thiazolidin-4-ones -- 8.3.2.1 Antiviral Activity -- 8.3.2.2 Anti-Inflammatory and Analgesic Activities -- 8.3.2.3 Anticancer Activity -- 8.3.2.4 Antibacterial and Antifungal Activities.
,
8.4 Thiadiazoles -- 8.4.1 Synthesis of Vicinal Diaryl Thiadiazoles -- 8.4.2 Biological Activity of Vicinal Diaryl Thiadiazoles -- 8.5 Conclusion -- References -- Further Reading -- Chapter 9: Vicinal Diaryl Oxadiazoles, Oxazoles, and Isoxazoles -- 9.1 Oxadiazoles -- 9.1.1 Synthesis of Some Vicinal Diaryl Oxadiazoles -- 9.1.2 Biological Spectrum of Vicinal Diaryl Oxadiazoles -- 9.1.2.1 Anticancer Agents -- 9.1.2.2 COX-2 Inhibitors -- 9.2 Oxazoles -- 9.2.1 Synthesis of Vicinal Diaryl Oxazoles -- 9.2.2 Biological Activities of Vicinal Diaryl Oxazoles -- 9.2.2.1 Anticancer Agents -- 9.2.2.2 COX-2 Inhibitors -- 9.3 Isoxazoles -- 9.3.1 Synthesis of Vicinal Diaryl Isoxazoles -- 9.3.2 Biological Activities of Vicinal Diaryl Isoxazoles -- 9.3.2.1 Anticancer Agents -- 9.3.2.2 COX Inhibitors -- 9.3.2.3 Antiosteoporotic Agents -- 9.4 Conclusion -- References -- Chapter 10: Chemical and Biological Profiles of Vicinal Diaryl-substituted Thiophenes, Imidazolines, Selendiazoles, and Is ... -- 10.1 Thiophenes -- 10.1.1 Synthesis of Vicinal Diaryl-Substituted Thiophenes -- 10.1.2 Biological Profile of Vicinal Diaryl-Substituted Thiophenes -- 10.2 Synthesis and Biological Spectrum of Vicinal Diaryl Imidazolines -- 10.3 Synthesis and Biological Activity of Vicinal Diaryl Heterocycles Containing Selenium -- 10.3.1 Selendiazole -- 10.3.2 Isoselenazole -- 10.4 Conclusion -- References -- Chapter 11: Synthesis and Biological Significance of Six- and Seven-membered Vicinal Diaryl Heterocycles -- 11.1 Introduction -- 11.2 Synthesis of Various Vicinal Diaryl Six-Membered Analogs -- 11.2.1 Synthesis of 1,2-Diarylbenzene (terphenyl) Derivatives -- 11.2.2 Synthesis of 1,6-Diarylpiperidine Derivatives -- 11.2.3 Synthesis of Vicinal 2,3-/5,6-Diarylpyridine Derivatives -- 11.2.4 Synthesis of 4,5-Diarylpyridazinone Derivatives.
,
11.2.5 Synthesis of 4,5-Diaryl-3,4-Dihydro-/4,5-Diarylpyrimidines.
Sprache:
Englisch
Bookmarklink